This white paper from Aptean describes why searches of intellectual property databases for biological sequences -- often done during the patent application process or to establish freedom to operate on a sequence -- may fail to turn up existing patented sequences.
Biological sequences have become an essential part of life science IP strategies, dependant on having access to complete and accurate information. If you aren't searching a comprehensive database, you may only be seeing ST.25 listings, leading to missing sequences. That missing data could more or less ruin your IP strategy.
Check out this whitepaper, where we reveal which patent assignees are notorious for patent applications that don’t strictly follow the ST.25 listings, and how that can become problematic for IP professionals.
Offered Free by: Aptean
See All Resources from: Aptean